Amarin Corp Plc (AMRN)

[OldYeller187]

Size of dossier won’t have an impact on being granted priority review. It might increase the rigor and duration of review, but the 6/10 month review window (depending on which we get) is plenty of time for them to go thru it.

Individual data listings and case report forms/narratives have to be generated + submitted for every patient/case, which is a huge amount of information (and work!) across those 8000 patients. That is monstrous...majority of Ph3 studies are a few thousand, max.